GSK plc (GSK)
NYSE: GSK · IEX Real-Time Price · USD
43.35
+0.78 (1.83%)
At close: May 2, 2024, 4:00 PM
43.21
-0.14 (-0.32%)
After-hours: May 2, 2024, 7:53 PM EDT
GSK Employees
GSK plc had 70,212 employees on December 31, 2023. The number of employees increased by 812 or 1.17% compared to the previous year.
Employees
70,212
Change (1Y)
812
Growth (1Y)
1.17%
Revenue / Employee
$561,304
Profits / Employee
$81,877
Market Cap
87.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70,212 | 812 | 1.17% |
Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
Dec 31, 2019 | 99,437 | 3,947 | 4.13% |
Dec 31, 2018 | 95,490 | -2,972 | -3.02% |
Dec 31, 2017 | 98,462 | -838 | -0.84% |
Dec 31, 2016 | 99,300 | -1,955 | -1.93% |
Dec 31, 2015 | 101,255 | 3,334 | 3.40% |
Dec 31, 2014 | 97,921 | -1,530 | -1.54% |
Dec 31, 2013 | 99,451 | -37 | -0.04% |
Dec 31, 2012 | 99,488 | 2,099 | 2.16% |
Dec 31, 2011 | 97,389 | 928 | 0.96% |
Dec 31, 2010 | 96,461 | -3,452 | -3.46% |
Dec 31, 2009 | 99,913 | 910 | 0.92% |
Dec 31, 2008 | 99,003 | -4,480 | -4.33% |
Dec 31, 2007 | 103,483 | 788 | 0.77% |
Dec 31, 2006 | 102,695 | 1,967 | 1.95% |
Dec 31, 2005 | 100,728 | 709 | 0.71% |
Dec 31, 2004 | 100,019 | -900 | -0.89% |
Dec 31, 2003 | 100,919 | -3,580 | -3.43% |
Dec 31, 2002 | 104,499 | -2,971 | -2.76% |
Dec 31, 2001 | 107,470 | -47 | -0.04% |
Dec 31, 2000 | 107,517 | -1,524 | -1.40% |
Dec 31, 1999 | 109,041 | -7,780 | -6.66% |
Dec 31, 1998 | 116,821 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
HCA Healthcare | 310,000 |
CVS Health | 300,000 |
Becton, Dickinson and Company | 73,000 |
Cigna | 72,500 |
McKesson | 51,000 |
Bristol-Myers Squibb Company | 34,100 |
Gilead Sciences | 18,000 |
Zoetis | 14,100 |
GSK News
- 6 hours ago - GSK knew about Zantac cancer risk, attorneys tell jury in first trial - Reuters
- 1 day ago - GSK raises full-year profit forecast - Reuters
- 2 days ago - FTC Warns ‘Junk Patents' Could Make Drugs Like Ozempic Pricier—Here's How - Forbes
- 2 days ago - FTC challenges ‘bogus' patents on Ozempic, other drugs that ‘block competition' - Market Watch
- 7 days ago - GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology - Reuters
- 15 days ago - GSK says efficacy of its shingles vaccine remains high after years - Reuters
- 6 weeks ago - Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease - GlobeNewsWire
- 6 weeks ago - GSK to cap out-of-pocket inhaler costs in US - Reuters